Novo Nordisk (NVO)
(Delayed Data from NYSE)
$127.51 USD
-7.37 (-5.46%)
Updated Sep 20, 2024 04:02 PM ET
After-Market: $127.94 +0.43 (0.34%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO11/6/24 |
---|---|
Current Quarter | 0.91 |
EPS Last Quarter | 0.65 |
Last EPS Surprise | -8.45% |
ABR | 1.46 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 3.11 |
Next Year | 4.34 |
EPS (TTM) | 2.92 |
P/E (F1) | 41.05 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.79B | 12.42B | 42.61B | 52.91B |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 10.91B | 13.38B | 43.63B | 53.81B |
Low Estimate | 10.70B | 11.81B | 41.71B | 51.86B |
Year ago Sales | 8.58B | 9.51B | 33.71B | 42.61B |
Year over Year Growth Est. | 25.80% | 30.63% | 26.40% | 24.17% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.91 | 0.97 | 3.11 | 4.34 |
# of Estimates | 4 | 3 | 5 | 5 |
Most Recent Consensus | NA | NA | 2.01 | NA |
High Estimate | 0.97 | 1.10 | 3.50 | 4.72 |
Low Estimate | 0.87 | 0.88 | 2.01 | 3.79 |
Year ago EPS | 0.73 | 0.71 | 2.70 | 3.11 |
Year over Year Growth Est. | 24.66% | 36.62% | 15.19% | 39.55% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.91 | 0.97 | 3.11 | 4.34 |
7 Days Ago | 0.91 | 0.97 | 3.11 | 4.34 |
30 Days Ago | 0.91 | 0.97 | 3.11 | 4.34 |
60 Days Ago | 0.93 | 0.93 | 3.33 | 4.35 |
90 Days Ago | 0.93 | 0.91 | 3.41 | 4.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.91 | 0.97 | 3.11 | 4.34 |
Zacks Consensus Estimate | 0.91 | 0.97 | 3.11 | 4.34 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.65 | 0.83 | 0.71 | 0.73 | NA |
Estimate | 0.71 | 0.77 | 0.66 | 0.69 | NA |
Difference | -0.06 | 0.06 | 0.05 | 0.04 | 0.02 |
Surprise | -8.45% | 7.79% | 7.58% | 5.80% | 3.18% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more